Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials

Overview of attention for article published in BMC Endocrine Disorders, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#43 of 799)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 9 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 41 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

M-A: Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus.

SPECIALTIES, 18 May 2022

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-ana…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.